Angiotensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat

Journal of Applied Physiology

Volumn 81, Issue 2, 1996, Pages 816-821

  Geenen, David L ^a   Malhotra, Ashwani ^a   Buttrick, Peter M ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

exercise; renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; EXERCISE; FEMALE; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SWIMMING; WEIGHT BEARING;

EID: 0029780935     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1996.81.2.816     Document Type: Article

References (29)

1. Bogoyevitch, M. A., P. J. Parker, and P. H. Sugden. Characterization of protein kinase C isotype expression in adult rat heart. Circ. Res. 72: 757-767, 1993.
2. Buttrick, P. M., M. Kaplan, L. A. Leinwand, and J. Scheuer. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J. Mol. Cell Cardiol. 26: 61-67, 1994.
3. Buttrick, P. M., A. Malhotra, S. Factor, D. Geenen, and J. Scheuer. Effects of chronic dobutamine administration on hearts of normal and hypertensive rats. Circ. Res. 63: 173-181, 1988.
4. Buttrick, P. M., C. Perla, M. A. Lahorra, A. Malhotra, D. L. Geenen, and J. Scheuer. The effect of chronic dobutamine on cardiac mechanics and biochemistry of chronic myocardial infarction in rats. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H473-H480, 1991.
5. Chang, R. S. L., P. K. S. Siegl, B. V. Clineschmidt, N. B. Mantlo, P. K. Chakravarty, A. A. Greenlee, and V. J. Lotti. In vitro pharmacology of L-158809, a new highly potent and selective angiotensin II receptor antagonist. J. Pharmacol. Exp. Ther. 262: 133-138, 1992.
6. 1) antagonist radioligand. Mol. Pharmacol. 42: 1077-1082, 1992.
7. Chomczynski, P. M., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
8. Cruickshank, J. M., J. Lewis, V. Moore, and C. Dodd. Reversibility of left ventricular hypertrophy (LVH) by differing types of anti-hypertensive therapy. J. Hum. Hypertens. 6: 85-90, 1992.
9. D'Albis, A., C. Pantaloni, and J. J. Bechet. An electrophoretic study of native myosin isoenzymes and of their subunit content. Eur. J. Biochem. 99: 261-272, 1979.
10. Geenen, D., P. Buttrick, and J. Scheuer. Cardiovascular and hormonal responses to swimming and running in the rat. J. Appl. Physiol. 65: 116-123, 1988.
11. Geenen, D. L., A. Malhotra, and J. Scheuer. Angiotensin II increases cardiac protein synthesis in adult rat heart. Am. J. Physiol. 265 (Heart. Circ. Physiol. 34): H238-H243, 1993.
12. Gupta, M. P., M. Gupta, A. Stewart, and R. Zak. Activation of α MHC gene expression by cAMP in cultured fetal rat heart myocytes. Biochem. Biophys. Res. Commun. 174: 1196-1203, 1991.
13. Kang, P. M., A. Nakouzi, T. Simpson, J. Scheuer, and P. M. Buttrick. Role of endogenous renin-angiotensin system in c-fos activation and PKC-∈ translocation in adult rat hearts. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): 2177-2183, 1996.
14. Kojima, M., I. Shiojima, T. Yamazaki, I. Komuro, Z. Yunzeng, W. Ying, T. Mizuno, K. Ueki, K. Tobe, T. Kadowaki, R. Nagai, and Y. Yazaki. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation 89: 2204-2211, 1994.
15. Kolbeck-Ruhmkorff, C., A. Horban, and H. G. Zimmer. Effect of pressure and volume overload on proto-oncogene expression in the isolated working rat heart. Cardiovasc. Res. 27: 1998-2004, 1993.
16. Lindpainter, K., and D. Ganten. The cardiac renin-angiotensin system. Circ. Res. 68: 905-921, 1991.
17. Malhotra, A., T. F. Schaible, J. Capasso, and J. Scheuer. Correlation of myosin isoenzyme alterations with myocardial function in physiologic and pathophysiologic hypertrophy. Eur. Heart J. 5, Suppl.: 61-67, 1984.
18. Phillips, M. I., E. A. Speakman, and B. Kimura. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul. Pept. 43: 1-20, 1992.
19. Sadoshima, J., and S. Izumo. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ. Res. 73: 413-423, 1993.
20. Sadoshima, J., and S. Izumo. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 12: 1681-1692, 1993.
21. Sadoshima, J., Y. Xu, H. S. Slayter, and S. Izumo. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75: 977-984, 1993.
22. Sadoshima, J., Q. Zhihua, J. P. Morgan, and S. Izumo. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, and 90-kD S6 kinase in cardiac myocytes. Circ. Res. 76: 1-15, 1995.
23. Samarel, A. M. In vivo measurements of protein turnover during muscle growth and atrophy. FASEB J. 5: 2020-2028, 1991.
24. Schaible, T. F., and J. Scheuer. Cardiac adaptations to chronic exercise. Prog. Cardiovasc. Dis. 27: 297-324, 1985.
25. Scheuer, J., and P. M. Buttrick. The cardiac hypertrophic response to physiologic and pathologic loads. Circulation 75: 163-168, 1987.
26. Scheuer, J., A. Malhotra, C. Hirsch, J. Cappaso, and T. F. Schaible. Physiologic cardiac hypertrophy corrects contractile protein abnormalities associated with pathologic hypertrophy in rats. J. Clin. Invest. 70: 1300-1305, 1982.
27. Schunkert, H., J. Sadoshima, T. Cornelius, Y. Kagaya, E. O. Weinberg, S. Izumo, G. Riegger, and B. H. Lorell. Angiotensin II-induced growth reponses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ. Res. 76: 489-497, 1995.
28. Siegl, P. K. S., R. S. L. Chang, N. B. Mantlo, P. K. Chakravarty, D. L. Ondeyka, W. J. Greenlee, A. A. Patchett, C. S. Sweet, and V. J. Lotti. In vivo pharmacology of L-158809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist. J. Pharmacol. Exp. Ther. 262: 139-144, 1992.
29. Zar, J. H. Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, 1974, p. 151-155.